batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Ono takes on Daiichi in tenosynovial giant cell tumour 17 February 2025 Galapagos tightens its focus 14 February 2025 China's 20th PD-(L)1 drug 13 February 2025 Enhertu goes pivotal in ovarian 12 February 2025 Tightening the Bolt on a questionable strategy 12 February 2025 SpringWorks gets an early second approval 12 February 2025 Bristol touts a marginal zone win 10 February 2025 Two more reasons for GSK to be wary of Tim-3 6 February 2025 Load More